Company Overview and News
Patterson Companies (PDCO - Free Report) recently partnered with Cure Partners to form a new business, Technology Partner Innovations, LLC. The business venture is gearing up to launch a cloud-based practice management software, NaVetor. Notably, NaVetor is a software designed for veterinary practices that can create and maintain electronic medical records (EMR).
CERN ATHN GHDX PDCO
Cerner Corporation (CERN - Free Report) is currently plagued with headwinds like downbeat guidance and stiff competition in niche space. Its no wonder that the company is underperforming in the MedTech space at the moment.
MDRX MCK MS.PRE MS.PRF MS.PRG QSII MS.PRA MS.PRI MS.PRK CERN SYK MS ABMD GHDX
Investors looking for stocks in the Medical Info Systems sector might want to consider either Computer Programs and Systems (CPSI - Free Report) or Cerner (CERN - Free Report) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.
It has been about a month since the last earnings report for Cerner Corporation (CERN - Free Report) . Shares have added about 3.9% in that time frame.
Ecolab Inc. (ECL - Free Report) recently launched a dynamic Health Department Intelligence (HDI) platform with a view to focus on food safety. The HDI platform retrieves and manages health department inspection data for foodservice operators and provides insights to help address food safety risks. This will help the company improve health inspection performance and manage food safety risks efficiently.
HAFC CERN ABMD ATHN AAP ECL AKAM
AAC Technologies Holdings Inc. (AACAY - Free Report) is an investment holding company. The Zacks Consensus Estimate for its current year earnings has been revised 6.1% downward over the last 30 days.
AMPH AHL.PRB AHL.PRC AHL.PRA AHL CERN AACAY AACAF AKAM AHL.PRD
Markets closed lower on Friday as trade negotiations between the United States and China continued to weigh on investors’ sentiment. Also, bond yields reached their highest level since 2011 last week. Bank stocks in particular took a hit. The S&P 500 and Nasdaq closed in the red, while the Dow barely managed to end the day higher.
WFC WFCNP WFC.WS BAC C TRU WFC.PRL WFC.PRJ BAC WFC.PRT WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN CERN WFC.PRY WFC.PRX WFC.PRW WFC.PRV
5h - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
2018-07-13 - Asif
Overview Catabasis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics based on its proprietary Safely Metabolized And Rationally Targeted linker, or SMART LinkerSM, drug discovery platform. The company's SMART Linker drug discovery platform enables it to engineer product candidates that can simultaneously modulate multiple targets in a disease. The company's proprietary product candidates impact pathways that are central to diseases where efficacy may be optimized by a multiple target approach. Catabasis Pharmaceuticals has applied its SMART Linker drug discovery platform to build an internal pipeline of product candidates for rare diseases, its primary focus, and plan to pursue partnerships to develop additional product candidates. The company's lead product candidate is edasalonexent, formerly known as CAT-1004, which the company believe has the potential to be a disease-modifying...
2018-07-09 - Asif
Overview Walmart Inc. helps people around the world save money and live better – anytime and anywhere – in retail stores and through eCommerce. Through innovation, Walmart is striving to create a customer-centric experience that seamlessly integrates its eCommerce and retail stores in an omni-channel offering that saves time for its customers. Each week, the company serve nearly 270 million customers who visit its more than 11,700 stores and numerous eCommerce websites under 65 banners in 28 countries. The company's strategy is to lead on price, invest to differentiate on access, be competitive on assortment and deliver a great experience. Leading on price is designed to earn the trust of its customers every day by providing a broad assortment of quality merchandise and services at everyday low prices ("EDLP"). EDLP is its pricing philosophy under which the company price items at a low price every day so its customers trust that its prices will not change under frequent prom...
Silicon Investor Message Boards
This table lists all message boards related to CERN / Cerner Corp. on message board site Silicon Investor.
as of ET